Schobel Alexander Mark

Officer at AQST

Sold, on record
$1.6M
Dollars the filings state
Form 4 sales
7
Latest Mar 15, 2024
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • AQSTAquestive Therapeutics, Inc.Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale AQSTPlan not stated
    Apr 29, 2020 2020

    Sold 40,000 shares at $4.50 ($180k)

    Schobel Alexander Mark, Chief Innovation/Tech Officer

    Sold 3.8% of holdings ($4.8M position)1M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale AQSTPlan not stated
    May 8, 2020 +9 days

    Sold 40,000 shares at $5.00 ($200k)

    Schobel Alexander Mark, Chief Innovation/Tech Officer

    Sold 4.2% of holdings ($4.7M position)902,113 shares leftFiling

  3. 3 Form 4 sale AQSTPlan not stated
    Feb 8, 2021 +276 days

    Sold 40,792 shares at $6.50 ($265k)

    Schobel Alexander Mark, Chief Innovation/Tech Officer

    Sold 4.5% of holdings ($5.9M position)872,000 shares left1x usual sizeFiling

  4. 4 Form 4 sale AQSTPlan not stated
    Feb 10, 2021 +2 days

    Sold 35,000 shares at $6.75 ($236k)

    Schobel Alexander Mark, Chief Innovation/Tech Officer

    Sold 4% of holdings ($5.9M position)837,000 shares left0.9x usual sizeFiling

  5. 5 Form 144 notice AQSTNotice
    Mar 8, 2024 +1122 days

    Filed to sell 25,000 shares ($140k)

    Schobel Alexander Mark, Officer

    10b5-1 planFirst sale on recordFiling

  6. 6 Form 4 sale AQSTRoutine
    Mar 8, 2024 same day

    Sold 25,000 shares at $5.19 ($130k)

    Schobel Alexander Mark, Chief Innovation/Tech Officer

    10b5-1 planSold 2.3% of holdings ($5.5M position)1M shares leftFirst sale on recordFollows a Form 144Filing

  7. 7 Form 144 notice AQSTNotice
    Mar 15, 2024 +7 days

    Filed to sell 50,000 shares ($300k)

    Schobel Alexander Mark, Officer

    10b5-1 planFiling

  8. 8 Form 4 sale AQSTRoutine
    Mar 15, 2024 same day

    Sold 50,000 shares at $6.00 ($300k)

    Schobel Alexander Mark, Chief Innovation/Tech Officer

    10b5-1 planSold 4.8% of holdings ($6.2M position)984,476 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Schobel Alexander Mark
Source
Mar 15, 2024Mar 19, 2024AQSTChief Innovation/Tech OfficerForm 4 sale50,000$300k4.8%RoutineSEC
Mar 15, 2024Mar 15, 2024AQSTOfficerForm 144 notice50,000$300kNoticeSEC
Mar 8, 2024Mar 12, 2024AQSTChief Innovation/Tech OfficerForm 4 sale25,000$130k2.3%RoutineSEC
Mar 8, 2024Mar 8, 2024AQSTOfficerForm 144 notice25,000$140kNoticeSEC
Feb 10, 2021Feb 10, 2021AQSTChief Innovation/Tech OfficerForm 4 sale35,000$236k4.0%Plan not statedSEC
Feb 8, 2021Feb 9, 2021AQSTChief Innovation/Tech OfficerForm 4 sale40,792$265k4.5%Plan not statedSEC
May 8, 2020May 11, 2020AQSTChief Innovation/Tech OfficerForm 4 sale40,000$200k4.2%Plan not statedSEC
Apr 29, 2020May 1, 2020AQSTChief Innovation/Tech OfficerForm 4 sale40,000$180k3.8%Plan not statedSEC
Apr 27, 2020May 4, 2020AQSTChief Innovation/Tech OfficerForm 4 sale80,000$308k7.8%Plan not statedSEC